Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical pharmacology of cyclophosphamide.

× No keyword cloud information.

68 in total

Review 1. Effect of haemodialysis on the pharmacokinetics of antineoplastic drugs.

Authors: Masatoshi Tomita; Yoichi Aoki; Kenichi Tanaka
Journal: Clin Pharmacokinet Date: 2004 Impact factor: 6.447

2. Cyclophosphamide-induced nephrotoxicity, genotoxicity, and damage in kidney genomic DNA of Swiss albino mice: the protective effect of Ellagic acid.

Authors: Muneeb U Rehman; Mir Tahir; Farrah Ali; Wajhul Qamar; Abdul Lateef; Rehan Khan; Abdul Quaiyoom; Sarwat Sultana
Journal: Mol Cell Biochem Date: 2012-06 Impact factor: 3.396

3. Kinetics of Cyclophosphamide Metabolism in Humans, Dogs, Cats, and Mice and Relationship to Cytotoxic Activity and Pharmacokinetics.

Authors: Dominique A Ramirez; Keagan P Collins; Allister E Aradi; Katherine A Conger; Daniel L Gustafson
Journal: Drug Metab Dispos Date: 2018-12-19 Impact factor: 3.922

Review 4. Antineoplastic drugs in 1990. A review (Part II).

Authors: D J Black; R B Livingston
Journal: Drugs Date: 1990-05 Impact factor: 9.546

5. Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients.

Authors: Maria Hedmer; Peter Höglund; Eva Cavallin-Ståhl; Maria Albin; Bo A G Jönsson
Journal: Int Arch Occup Environ Health Date: 2007-06-20 Impact factor: 3.015

6. Antineoplastic activity of ASTA Z 7557 (INN mafosfamide) in transplanted and autochthonous experimental rodent tumors.

Authors: W J Zeller; M R Berger; R Matys; J Schuhmacher
Journal: Invest New Drugs Date: 1984 Impact factor: 3.850

7. Comparative effects of ASTA Z 7557 (INN mafosfamide) and cyclophosphamide on hematopoiesis in mice.

Authors: M R Nowrousian; C G Schmidt
Journal: Invest New Drugs Date: 1984 Impact factor: 3.850

8. Population pharmacokinetics analysis of cyclophosphamide with genetic effects in patients undergoing hematopoietic stem cell transplantation.

Authors: In-Wha Kim; Hwi-yeol Yun; Boyoon Choi; Nayoung Han; Myeong Gyu Kim; Seonyang Park; Jung Mi Oh
Journal: Eur J Clin Pharmacol Date: 2013-04-16 Impact factor: 2.953

9. Effect of renal insufficiency on the pharmacokinetics of cyclophosphamide and some of its metabolites.

Authors: F D Juma; H J Rogers; J R Trounce
Journal: Eur J Clin Pharmacol Date: 1981 Impact factor: 2.953

10. The disposition of cyclophosphamide in a group of myeloma patients.

Authors: V Bramwell; R T Calvert; G Edwards; H Scarffe; D Crowther
Journal: Cancer Chemother Pharmacol Date: 1979 Impact factor: 3.333